Showing results (321-330 of 363) with videos related to

Sort By:
Pageof 37
Diabetes, Obesity & Metabolism|September 28, 2018
Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: A randomized crossover trialMyfanwy C Geyer, Thomas Sullivan, Andrew Tai, et al.
The Australian and New Zealand Journal of Psychiatry|May 12, 2023
A randomised controlled trial of a psychoeducational group intervention for family and friends of young people with borderline personality disorder featuresJennifer K Betts, Mirra R Seigerman, Carol Hulbert, et al.
Endocrinology|November 21, 2024
Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal MotilityRyan J Jalleh, Chinmay S Marathe, Christopher K Rayner, et al.
The Journal of Clinical Endocrinology and Metabolism|October 17, 2024
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and TirzepatideRyan J Jalleh, Mark P Plummer, Chinmay S Marathe, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 6, 2007
Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin releaseReawika Chaikomin, Keng Liang Wu, Selena Doran, et al.
The Journal of Clinical Endocrinology and Metabolism|August 9, 2019
Longitudinal Changes in Fasting and Glucose-Stimulated GLP-1 and GIP in Healthy Older SubjectsHung Pham, Chinmay S Marathe, Liza K Phillips, et al.
Journal of Gastroenterology and Hepatology|May 30, 2024
Genomic analysis of Helicobacter pylori in Australia: Antimicrobial resistance, phylogenetic patterns, and virulence factorsJonathon P Schubert, Alfred Tay, Khui Hung Claire Lee, et al.
Acta Diabetologica|December 19, 2019
The relationship between plasma GIP and GLP-1 levels in individuals with normal and impaired glucose toleranceChinmay S Marathe, Hung Pham, Jessica A Marathe, et al.
Pageof 37